Materials and methods
N-α-Fmoc-protected amino acids for peptide synthesis, PyBOP coupling reagent and resins were obtained from Novabiochem or Iris Biotech. Other reagents for peptide synthesis, solvents, buffers and metal salts were purchased from Sigma-Aldrich. Analytical HPLC separations were performed on an Agilent Infinity 1200 system using PurospherStar (Merck) RP-18e 150 mm  4.6 mm or Chromolith (Merck) RP-18e 100 mm  4.6 mm columns at 1 and 2 mL/min, respectively. Preparative HPLC separations were performed on a VWR LaPrep system using a XBridge Prep (Waters) C18 5 µm 150-19mm column. Mobile phase consisted in a gradient of solvent A (0.1% TFA in H 2 O) and B (0.1% TFA in MeCN/H 2 O 9:1) or C (0.1% TFA in MeOH/H 2 O 9:1). ESI-MS analyses were performed on a Thermo LXQ spectrometer. LC/MS analyses were performed in Q1 MS mode using a Thermo Quantum Ultra electrospray mass spectrometer equipped with a Accela HPLC system. Separations were performed using an Uptisphere (Interchim) C18 10 x 2.1 mm, 3µm, column, eluted with a linear gradient of acetonitrile, from 0 to 30% in 30 min in 0.1% TFA, the flow rate being 200 µl/min. UV-Vis spectra were recorded on a Perkin-Elmer Lambda 35 spectrophotometer or on a Varian Cary 50 spectrophotometer. Fluorescence spectra were recorded on a Cary Eclipse spectrometer. Stopped-flow kinetic measurements were performed using a Bio-Logic SFM-400 stopped-flow device coupled to a MOS-450 AF-CD spectrometer equipped with a TC100/10F quartz cuvette (1 cm pathlength). The stopped-flow apparatus was thermo-regulated using circulating water bath. All buffer or metal solutions for spectroscopic measurements were prepared with MilliQ water (Millipore). Buffer solutions were treated with Chelex 100 resin (Biorad) to remove metal traces. HOCl solutions were prepared by dilution of a 2% NaOCl stock solution and stored at 4°C.
The HOCl concentration was determined prior to use by measuring the absorbance at 292 nm ( NaOCl = 350 M -1 cm -1 ) at pH 12. [1] Peptide L HSP was synthesized as described previously. [2] Solutions of Zn·L HSP were prepared under inert atmosphere (argon) by adding 1.1 eq. Zn 2+ to a solution of free peptide (1-1.5 mM) in H 2 O (exact concentration determined by Ellman's assay) [3] and adjusting the pH to 7.0 with NaOH and HCl. 
Oxidation of Zn·L HSP by HOCl: HPLC analyses
A solution of Zn·L HSP (35 µM) in a phosphate buffer (50 mM, pH 7.0) was prepared by diluting a stock solution of Zn·L HSP (ca. 400 µM) in the buffer and water (final volume 500 µL). An aliquot of a 20 mM HOCl solution (corresponding to 1-5 equivalent) was added to the complex solution. The mixture was stirred for 10 seconds and a methionine solution (100 mM, 50 µL) was added to destroy excess HOCl. After 30 s, the solution was analysed by analytical HPLC (Purospher Star RP-18e, 5 to 34% B gradient in 18 minutes, 1 mL/min).
Identification of bis-disulfide products
The three bis-disulfide forms of L HSP were prepared by reacting Zn·L HSP in a phosphate buffer (100 mM, pH 7.0) with H 2 O 2 or HOCl on a preparative scale (10 mg Zn·L HSP in 3 mL buffer). Bis-disulfides were separated by preparative HPLC and lyophilized. Oxidized peptides (0.25 mg) were dissolved in a phosphate (25 mM, pH 7.0, 250 µL). Trypsin (100 µg/mL, 30 µL) or both Trypsin (100 µg/mL, 30 µL) and/or Glutamate carboxypeptidase 
Stopped-flow experiments
The kinetics of the reaction of Zn·L HSP with HOCl (or ClO -) was measured on a Biologic stopped-flow apparatus with the following typical procedure at various pH values. For this purpose, a set of phosphate buffer solutions (20 mM, ionic strength I = 0.62 ± 0.02) covering the pH range 10.5-13.5 was prepared by diluting stock solutions of Na 2 HPO 4 0.1 M and NaClO 4 0.8 M and adjusting the pH to the desired value using NaOH. Stock solutions of Zn·L HSP (1-1.5 mM) and NaOCl (2-5 mM) were prepared in water (their concentration was determined as described above). Prior to stopped-flow experiments, these stock solutions were diluted with a phosphate buffer to 2-10 µM and 50-800 µM, respectively. The four syringes of the stopped-flow apparatus were filled with water, buffer, NaOCl solution and Zn·L HSP solution and the temperature was maintained at 25°C using a circulating bath. Lines were thoroughly washed with water and buffer before each shot, which consisted of the fast mixing of buffer, NaOCl and Zn·L HSP solutions in various proportions. The reaction was monitored by recording the decay of the RS - Zn 2+ ligand to metal charge transfer absorption at 230 nm (this wavelength was a compromise between the intensity of the absorption band and the light intensity of the lamp). The recording time was adjusted from 160 ms to 8 ms in order to record the full kinetics and ensure that a plateau is reached. The NaOCl and Zn·L HSP concentrations were varied by changing the volume ratio of the mixed solutions but always keeping [NaOCl] > 10[Zn·L HSP ] so as to maintain pseudo-first-order conditions. For each condition, shots were accumulated, aberrant data were removed and kinetic traces were averaged to reduce noise.
The pseudo-first-order rate constant k obs (s -1 ) was determined by fitting the averaged trace to a mono-exponential decay. In order to check that the absorbance decay corresponds to the oxidation of the four cysteines, the amplitude of the absorbance decay at 230 nm (pH 12) was compared to the absorbance loss at 230 nm obtained [4] Figure S5 shows the data obtained for these competitions, which give k app (Met)/k app (FmocMet) = 1.22 ± 0.03. al. [4] This gave the same ratio within error margin: k app (Met)/k app (FmocMet) = 1.29 ± 0.12. Therefore, our competition experiments lead to a new experimental value for k app (Met) at pH 7.4, (1.9 ± 0.3)10 8 M -1 s -1 , which is ca. one order of magnitude higher than that proposed by Storkey et al. 
